Omadacycline: A New Tetracycline Antibiotic.
CONCLUSION: Omadacycline is an alternative treatment option for ABSSSI and CABP.
PMID: 30917674 [PubMed - in process]
Source: The Annals of Pharmacotherapy - Category: Drugs & Pharmacology Authors: Dougherty JA, Sucher AJ, Chahine EB, Shihadeh KC Tags: Ann Pharmacother Source Type: research
More News: Avelox | Bacterial Pneumonia | Chemistry | Clinical Trials | Conferences | Drugs & Pharmacology | Linezolid | Microbiology | Moxifloxacin | MRSA | Pneumonia | Skin | Study | Tetracycline | Websites | Zyvox